Group One Trading’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-400
| Closed | -$3K | – | 8580 |
|
|
2022
Q2 | $3K | Hold |
400
| – | – | ﹤0.01% | 7364 |
|
|
2022
Q1 | $4K | Sell |
400
-700
| -64% | -$5.4K | ﹤0.01% | 7594 |
|
|
2021
Q4 | $8K | Sell |
1,100
-131,600
| -99% | -$1.38M | ﹤0.01% | 7490 |
|
|
2021
Q3 | $1.51M | Buy |
132,700
+128,800
| +3,303% | +$1.88M | ﹤0.01% | 2951 |
|
|
2021
Q2 | $62K | Sell |
3,900
-900
| -19% | -$15.4K | ﹤0.01% | 6398 |
|
|
2021
Q1 | $858K | Buy |
4,800
+4,400
| +1,100% | +$76K | ﹤0.01% | 3415 |
|
|
2020
Q4 | $5K | Buy |
+400
| New | +$4.83K | ﹤0.01% | 6057 |
|
|
2020
Q3 | – | Sell |
-100
| Closed | -$1K | – | 6720 |
|
|
2020
Q2 | $1K | Sell |
100
-1,100
| -92% | -$16.3K | ﹤0.01% | 5696 |
|
|
2020
Q1 | $16K | Sell |
1,200
-800
| -40% | -$15.2K | ﹤0.01% | 4363 |
|
|
2019
Q4 | $48K | Sell |
2,000
-15,600
| -89% | -$323K | ﹤0.01% | 4027 |
|
|
2019
Q3 | $338K | Buy |
17,600
+13,300
| +309% | +$305K | ﹤0.01% | 2673 |
|
|
2019
Q2 | $127K | Buy |
4,300
+2,400
| +126% | +$92.5K | ﹤0.01% | 3170 |
|
|
2019
Q1 | $90K | Sell |
1,900
-18,600
| -91% | -$819K | ﹤0.01% | 3249 |
|
|
2018
Q4 | $740K | Buy |
20,500
+900
| +5% | +$42.2K | 0.01% | 1722 |
|
|
2018
Q3 | $1.21M | Sell |
19,600
-200
| -1% | -$12.9K | 0.01% | 1552 |
|
|
2018
Q2 | $1.34M | Sell |
19,800
-2,900
| -13% | -$162K | 0.01% | 1437 |
|
|
2018
Q1 | $1.23M | Sell |
22,700
-700
| -3% | -$39.1K | 0.01% | 1354 |
|
|
2017
Q4 | $1.4M | Buy |
23,400
+17,800
| +318% | +$1.08M | 0.01% | 1440 |
|
|
2017
Q3 | $272K | Buy |
5,600
+3,900
| +229% | +$213K | ﹤0.01% | 2541 |
|
|
2017
Q2 | $89K | Buy |
1,700
+500
| +42% | +$23.3K | ﹤0.01% | 3187 |
|
|
2017
Q1 | $54K | Sell |
1,200
-4,100
| -77% | -$183K | ﹤0.01% | 3357 |
|
|
2016
Q4 | $201K | Sell |
5,300
-55,000
| -91% | -$2.08M | ﹤0.01% | 2420 |
|
|
2016
Q3 | $2.28M | Buy |
60,300
+31,200
| +107% | +$688K | 0.02% | 784 |
|
|
2016
Q2 | $512K | Sell |
29,100
-900
| -3% | -$14.6K | 0.01% | 1716 |
|
|
2016
Q1 | $365K | Buy |
30,000
+19,700
| +191% | +$312K | 0.01% | 1923 |
|
|
2015
Q4 | $251K | Sell |
10,300
-21,700
| -68% | -$506K | ﹤0.01% | 2322 |
|
|
2015
Q3 | $568K | Buy |
32,000
+1,700
| +6% | +$30.8K | 0.01% | 1670 |
|
|
2015
Q2 | $535K | Buy |
30,300
+20,300
| +203% | +$372K | 0.01% | 1723 |
|
|
2015
Q1 | $313K | Buy |
+10,000
| New | +$290K | ﹤0.01% | 1999 |
|
Group One Trading's AERI Position: Q4 2022 in Review
Group One Trading sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 1,576 shares — an estimated $24K sold.
Group One Trading first reported a position in AERI in Q2 2015 and held it in 16 quarters. The position peaked at $2.03M in Q2 2019. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.
- Group One Trading reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
- Group One Trading sold 1,576 Aerie Pharmaceuticals shares in Q4 2022, an estimated $24K.
- Group One Trading first reported a position in Aerie Pharmaceuticals in Q2 2015 and held it in 16 quarters.
- Group One Trading's Aerie Pharmaceuticals position peaked at $2.03M in Q2 2019.
- 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.
Based on Group One Trading's 13F filing for Q4 2022, filed 9 Feb 2023.